Full Text View
Tabular View
No Study Results Posted
Related Studies
Pancreatic Stent to Prevent Leak After Distal Pancreatectomy (LEAPS)
This study is enrolling participants by invitation only.
First Received: May 1, 2008   Last Updated: May 2, 2008   History of Changes
Sponsors and Collaborators: Massachusetts General Hospital
American Society for Gastrointestinal Endoscopy
Information provided by: Massachusetts General Hospital
ClinicalTrials.gov Identifier: NCT00671463
  Purpose

The purpose of this study is to investigate an intervention to prevent complications after pancreas surgery. The goal is to determine if placing a stent into the pancreatic duct before surgery will decrease or prevent leaking from the pancreatic duct after surgery. Leaks are common after pancreas surgery and can result in serious problems and post-operative pain. The study will compare two groups. One group will have the stent before surgery, and the other group will have standard pancreas surgery, no endoscopy, and no stent.


Condition Intervention
Pancreatic Surgery
Pancreatic Duct Stenting
Pancreatic Cancer
Distal Pancreatectomy
Pancreatic Diseases
Pancreatic Cyst
Pancreatic Ducts
Procedure: Pancreatic duct stenting

Study Type: Interventional
Study Design: Prevention, Randomized, Single Blind (Outcomes Assessor), Active Control, Parallel Assignment
Official Title: Leak Elimination After Pancreatic Stenting, a Randomized Controlled Trial

Resource links provided by NLM:


Further study details as provided by Massachusetts General Hospital:

Primary Outcome Measures:
  • Pancreatic leak [ Time Frame: Post-operative day 3 ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Peritoneal fluid analysis [ Time Frame: Daily ] [ Designated as safety issue: No ]
  • Serum biochemical analysis [ Time Frame: Daily ] [ Designated as safety issue: No ]
  • Clinical outcomes [ Time Frame: Daily ] [ Designated as safety issue: No ]

Estimated Enrollment: 80
Study Start Date: April 2008
Estimated Primary Completion Date: April 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1: Experimental
Pre-operative pancreatic duct stenting
Procedure: Pancreatic duct stenting
In the treatment arm, patients will have a pancreatic duct stent placed prior to having their distal pancreatectomy.
2: No Intervention
Control group, no endoscopy and no stent pre-operatively

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Adult patients (greater than or equal to 18 years of age)
  • Scheduled to undergo an elective laparoscopic or open distal pancreatectomy
  • Willing to undergo pre-operative endoscopy
  • Consenting to the procedure

Exclusion Criteria:

  • Contraindication to abdominal surgery
  • Contraindication to general anesthesia or distal pancreatectomy
  • Contraindication to upper endoscopy or ERCP
  • Prior history of gastric bypass or other abdominal surgery in whom the ampulla will not be accessible via routine ERCP
  • Ongoing pancreatitis
  • Pancreatic necrosis or abscess
  • History of sphincter of Oddi dysfunction
  • History of ERCP-induced pancreatitis
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00671463

Locations
United States, Massachusetts
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114
Sponsors and Collaborators
Massachusetts General Hospital
American Society for Gastrointestinal Endoscopy
Investigators
Study Director: Field F Willingham, MD, MPH MGH
Study Director: Denise W Gee, MD MGH
Study Director: Sevdenur Cizginer, MD MGH
Principal Investigator: David W Rattner, MD MGH
Principal Investigator: William R Brugge, MD MGH
  More Information

No publications provided

Responsible Party: Massachusetts General Hospital ( William Brugge, MD / Director of Endoscopy )
Study ID Numbers: 2007P000965
Study First Received: May 1, 2008
Last Updated: May 2, 2008
ClinicalTrials.gov Identifier: NCT00671463     History of Changes
Health Authority: United States: Institutional Review Board

Keywords provided by Massachusetts General Hospital:
Pancreas surgery
Pancreatic adenocarcinoma
Pancreatic neuroendocrine tumor
Pancreatic duct stenting

Study placed in the following topic categories:
Digestive System Neoplasms
Pancreatic Neoplasms
Endocrine System Diseases
Cysts
Pancrelipase
Neuroendocrine Tumors
Digestive System Diseases
Pancreatic Cyst
Pancreatic Diseases
Gastrointestinal Neoplasms
Endocrinopathy
Adenocarcinoma
Endocrine Gland Neoplasms

Additional relevant MeSH terms:
Neoplasms
Neoplasms by Site
Digestive System Neoplasms
Digestive System Diseases
Pancreatic Cyst
Pancreatic Neoplasms
Endocrine System Diseases
Pancreatic Diseases
Cysts
Endocrine Gland Neoplasms

ClinicalTrials.gov processed this record on July 02, 2009